2024-03-29T09:31:09Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_3754407C879B
2024-03-23T02:11:41Z
serval:BIB_3754407C879B
Electroporation as a method of choice to generate genetically modified dendritic cell cancer vaccines.
10.1016/j.copbio.2020.02.009
000589902000019
32240923
Ahmed
R.
author
Sayegh
N.
author
Graciotti
M.
author
Kandalaft
L.E.
author
article
review
2020-10
Current opinion in biotechnology
1879-0429
0958-1669
journal
65
142-155
Cancer Vaccines
Dendritic Cells
Electroporation
Humans
Immunotherapy
Neoplasms/genetics
Neoplasms/therapy
eng
60_published
peer-reviewed
Publication types: Journal Article ; Research Support, Non-U.S. Gov't ; Review
Publication Status: ppublish